Prognosis of Single and Multiple TP53 Abnormalities Differs in Treatment-Naïve Patients With High-Count MBL and CLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Differential prognosis of single and multiple TP53 abnormalities in high count MBL and untreated CLL
Blood Adv 2023 Mar 06;[EPub Ahead of Print], R Griffin, JE Wiedmeier-Nutor, SA Parikh, CE McCabe, DR O'Brien, NJ Boddicker, G Kleinstern, KG Rabe, L Bruins, S Brown, C Bonolo de Campos, W Ding, JF Leis, PJ Hampel, TG Call, D Van Dyke, NE Kay, JR Cerhan, H Yan, SL Slager, E BraggioFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.